Delivery Order SPE2DB24D2205-SPE2DB25FEGAD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Ofev 150 mg capsules (60-count units). The contract represents a firm fixed-price delivery order with an ultimate completion date of August 25, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. No set-aside designation was used in this competitive award. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Ofev 150 mg capsules (60-unit packages) with a ceiling value of $8,590.58. This firm fixed-price delivery order is scheduled for completion by August 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a non-competitive delivery order issued under AmerisourceBergen's existing contract vehicle...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp for 60 capsules of Ofev 150 mg on July 25, 2025, with an ultimate completion date of August 15, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a delivery order under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be performed from the contractor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $8,630.28 to AmerisourceBergen Drug Corp for OFEV 100 mg capsules (60-count units) on July 23, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Ofev 150 mg capsules (60-count units) under a firm fixed-price contract valued at $8,590.58, with completion targeted for August 20, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Ofev 150 mg capsules (60-count units) valued at $8,590.58 under a firm fixed price arrangement. The contract was competitively awarded without a set-aside designation and is scheduled for completion by August 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a $8,590.58 delivery order to AmerisourceBergen Drug Corp for OFEV 150 mg capsules (60-count units) on July 21, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price contract represents a non-competitive set-aside and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp for OFEV (nintedanib) 150 mg capsules (60-count units) on July 18, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order represents a non-set-aside award, indicating it was competitively procured. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract action, this delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of OFEV 100 mg capsules (60-count units) valued at $8,630.28. This is a firm fixed-price delivery order with an ultimate completion date of August 21, 2025, and represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of OFEV 150 mg capsules (60-count units) under a firm fixed-price arrangement. The contract, valued at $8,590.58, was competitively awarded without any set-aside designation and carries an ultimate completion date of August 15, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery from its...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEGADDelivery Order
The Defense Logistics Agency awarded a $25,771.74 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Ofev 150 mg capsules (60-count units). This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 29, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant federal contract portfolio focused on supporting military and veteran healthcare systems through the DLA Medical Supply Chain. The company's delivery orders consistently feature firm fixed pricing structures and demonstrate capability across a diverse range of pharmaceutical products and medical supplies. This particular delivery order for Ofev, a medication commonly used in pulmonary disease treatment, exemplifies the company's role as a critical vendor for specialized pharmaceutical procurement within the federal healthcare system and supports the broader Defense Health Agency mission of ensuring adequate medical supplies for military personnel and beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.8k | 8/8/25 |